CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...